FDA Grants Revascor® (Rexlemestrocel-L) Regenerative Medicine Advanced Therapy (RMAT) Designation in Children with Congenital Heart Disease

Published: 12/05/2024

FDA Grants Revascor® (Rexlemestrocel-L) Regenerative Medicine Advanced Therapy (RMAT) Designation in Children with Congenital Heart Disease

tags

Latest News

NEWS 03.12.2026

Allowing Stem Cells Space to Thrive – BIOENGINEER.ORG

NEWS 03.12.2026

Two Live Births Achieved Through Stem Cell Therapy in New Delhi – The News Mill

NEWS 03.12.2026

Who Is Dr. Charles Pereyra? The Physician Bringing Regenerative Longevity Medicine to the Mainstream – The UBJ

NEWS 03.12.2026

Hip/Knee Injuries Spike Every Spring & Specialists at Pain Physicians NY Say Regenerative Therapies Can Prevent Surgery – The Desert Sun